Major Fs
genetic predisposition to type I hypersensitivity (atopy),
acute and chronic airway infl,
bronchial hyperresponsiveness to a variety of stimuli.
subclassified as atopic (evidence of allergen sensitization) or nonatopic.
In both: episodes of bronchospasm may be triggered by diverse exposures, such as respiratory infections (esp viral), airborne irritants (e.g., smoke, fumes), cold air, stress, and exercise.
varying patterns of infl—eosinophilic (most common), neutrophilic, mixed infl, and pauci-granulocytic—that are a. w/ differing etiologies, immunopathologies, and responses to treatment.
classic atopic form:
excessive TH2 cell activation--> IL-4 and IL-13 (IgE production), IL-5 (activates eosinophils), and IL-13 (stimulates mucus production); IgE coats submucosal mast cells...
Mast cell–derived mediators--> two waves of reaction:
• early-phase reaction: dominated by bronchoconstriction, incr mucus production, and vasodilation; Bronchoconstriction triggered by mediators released from mast cells (histamine, PGD2, and LTC4, D4, and E4) and also by reflex neural pathways
• late-phase reaction: infl in nature.
Infl mediators--> epith cells produce chemokines (incl eotaxin, a potent chemoattractant and activator of eosinophils)--> recruitment of TH 2 cells, eosinophils, and etc--> amplifying an infl reaction that is initiated by resident immune cells.
• Repeated bouts of infl--> structural changes in bronchial wall: airway remodeling: hypertrophy of bronchial smooth muscle and mucus glands + incr vascularity and deposition of subepith coll, which may occur as early as several yrs before initiation of symptoms.
Asthma tends to “run” in families, but role of genetics complex.
a number of genetic variants a.: genes enocoding factors like IL-4 R